#longevity #geroscience #pulmonaryhypertension #biotech #aging 35Pharma To view or add a comment, sign in Insulin Icodec = Once-Weekly Insulin Revolution Remember it with this mnemonic: I-C-O-D-E-C I = Inject once weekly C = Convenience improved (fewer injections, better adherence) O = Optimized glycemic control D = Designed for long duration (7-day basal coverage) E = Eases treatment burden C = Changing diabetes care Insulin icodec is a novel once-weekly basal insulin analog developed to simplify diabetes management and potentially improve adherence compared with daily basal insulin regimens
Several factors can influence the speed of your results: Individual Metabolism: Every body processes medication differently
Relying on the RDA alone 0.8 g/kg prevents deficiency but is low for active adults, older adults, and anyone losing weight on GLP-1
Beyond that landmark study, the evidence base includes research showing GHK-Cu enlarges hair follicle size, extends the anagen (active growth) phase, stimulates dermal papilla cells (the cells that control follicle activity), promotes angiogenesis (blood vessel growth) to the scalp, and reduces the DHT-related inflammation that causes follicle miniaturization in androgenetic alopecia
The recommended dosage of Farxiga A patients age, kidney function, and other medical conditions, as well as the condition being treated, might all affect the recommended dosage of Farxiga (dapagliflozin)
Indian generics are usually cheaper than imported innovator brands, and generic semaglutide specifically has become far cheaper since its patent expired in March 2026
